Apply for the Servier Golden Ticket 2025 – a chance to accelerate your research and development effort

Applications are now open for the Servier Golden Ticket – a program sponsored by Servier in collaboration with SmiLe Venture Hub, designed to support a promising startup in oncology or neuroscience developing groundbreaking therapeutics, platform technologies or AI/ML data-driven platforms for drug discovery.  

Servier is a leading French pharmaceutical company, ranked 35th globally and 2nd in France. It operates in over 150 countries, with 22,000 employees and a strong focus on innovation and scientific advancement. 

The Servier Golden Ticket winner will receive one year of access to a lab bench and office space at SmiLe Venture Hub in Lund, state-of-the-art facilities and equipment, mentorship and business coaching from SmiLe, direct engagement with Servier’s scientific experts and industry advisors, and exclusive access to both Servier’s and SmiLe’s networks. 

The application deadline is May 1, 2025.

Read more and apply at: smileventurehub.com/servier-golden-ticket

For questions, contact: 

Thomas Areschoug, Business Coach and Head of Industry Relations at SmiLe Venture Hub, 

thomas.areschoug@smileventurehub.com